[HTML][HTML] First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck …
Y Guo, Y Luo, Q Zhang, X Huang, Z Li, L Shen… - European Journal of …, 2021 - Elsevier
Background The EXTREME regimen (chemotherapy [CT; cisplatin/carboplatin and 5-
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …
Platinum‐based chemotherapy plus cetuximab first‐line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of …
Y Guo, M Shi, A Yang, J Feng, X Zhu, YJ Choi… - Head & …, 2015 - Wiley Online Library
Background The purpose of this study was to assess the efficacy, safety, and
pharmacokinetics of cisplatin‐based chemotherapy plus cetuximab as first‐line treatment in …
pharmacokinetics of cisplatin‐based chemotherapy plus cetuximab as first‐line treatment in …
Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head …
T Yoshino, Y Hasegawa, S Takahashi… - Japanese Journal of …, 2013 - academic.oup.com
Objective To assess the efficacy and safety of cetuximab in combination with cisplatin and 5-
fluorouracil for first-line treatment of Japanese patients with recurrent and/or metastatic …
fluorouracil for first-line treatment of Japanese patients with recurrent and/or metastatic …
Cetuximab, docetaxel, and cisplatin (TPEx) as first-line treatment in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN …
J Guigay, J Fayette, A Dillies, C Sire… - Journal of Clinical …, 2011 - ascopubs.org
5567 Background: Cetuximab in combination with platinum and 5FU has become a
standard in first-line treatment of patients (pts) with R/M SCCHN. Cetuximab and taxane …
standard in first-line treatment of patients (pts) with R/M SCCHN. Cetuximab and taxane …
[HTML][HTML] Evidence-based treatment options in recurrent and/or metastatic squamous cell carcinoma of the head and neck
A Argiris, KJ Harrington, M Tahara, J Schulten… - Frontiers in …, 2017 - frontiersin.org
The major development of the past decade in the first-line treatment of recurrent and/or
metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the …
metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the …
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck …
J Guigay, A Aupérin, J Fayette, E Saada-Bouzid… - The Lancet …, 2021 - thelancet.com
Background Results from a phase 2 trial of the TPEx chemotherapy regimen (docetaxel–
platinum–cetuximab) showed promising results, with a median overall survival of 14· 0 …
platinum–cetuximab) showed promising results, with a median overall survival of 14· 0 …
Cetuximab, docetaxel, and cisplatin (TPEx) as first-line treatment in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN …
J Guigay, J Fayette, AF Dillies, C Sire, JN Kerger… - 2012 - ascopubs.org
5505 Background: Cetuximab in combination with platinum and 5FU (PFEx) has become a
standard in first-line treatment of patients (pts) with R/M SCCHN. Cetuximab and taxane …
standard in first-line treatment of patients (pts) with R/M SCCHN. Cetuximab and taxane …
Platinum-based chemotherapy (CT) plus cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck cancer (R/M-SCCHN): 5-year follow-up …
JB Vermorken, E Remenar, R Hitt, A Kawecki, S Rottey… - 2014 - ascopubs.org
6021^ Background: The EXTREME trial demonstrated that patients with R/M-SCCHN benefit
significantly from the addition of cetuximab to first-line platinum-based CT in relation to …
significantly from the addition of cetuximab to first-line platinum-based CT in relation to …
Randomized phase ii study with cetuximab in combination with 5-FU and cisplatin or carboplatin vs. cetuximab in combination with paclitaxel and carboplatin for …
G Tsakonas, L Specht, CA Kristensen, MHC Moreno… - Cancers, 2020 - mdpi.com
Simple Summary The purpose of the CET-MET trial was to find a new platinum-based
chemotherapy regimen in combination with cetuximab for relapsed or metastatic squamous …
chemotherapy regimen in combination with cetuximab for relapsed or metastatic squamous …
[HTML][HTML] Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter …
J Guigay, J Fayette, AF Dillies, C Sire, JN Kerger… - Annals of …, 2015 - Elsevier
Background Cetuximab in combination with platinum and 5-fluorouracil is the standard of
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …